China Resources Double-Crane Pharmaceutical Co.,Ltd. (600062.SS)
Makes prescription medicines for blood pressure, diabetes, cancer, and other common diseases across China.
16.89+0.03%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-18.8%
The outlook
China Resources Double-Crane trades at 16.89, sitting near its 52-week low with a modest trailing P/E of 10.8. Price action is mixed relative to moving averages, and the overall sentiment leans bearish among available data. Analyst coverage appears thin on this Chinese pharmaceutical stock.
What’s behind the score
Price trendMixed vs its moving averages
52-week range23% of the way from its 52-week low to high
Market cap
$17.54B
52-wk high
22.14
52-wk low
15.29
50-day avg
16.79
200-day avg
18.09
Trailing P/E
10.8